Fresh From $750M Settlement, Medinol To Pursue Further Royalties From Boston Scientific
Israeli medical device maker Medinol, fresh from winning a $750 million settlement from Boston Scientific Corp. over sales of coronary stents, plans to pursue future royalties on a next-generation stent, according...To view the full article, register now.
Already a subscriber? Click here to view full article